9 research outputs found

    Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

    No full text

    Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    No full text
    corecore